These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32076942)

  • 1. Nonselective β-Blockers May Progress the Thrombosis of Portal Venous System in Cirrhotic Patients: A Retrospective Observational Study.
    Xu X; Xu S; Primignani M; De Stefano V; He Y; Yi F; Guo X; Valla D; Qi X
    Adv Ther; 2020 Apr; 37(4):1452-1463. PubMed ID: 32076942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonselective β-blockers may induce development of portal vein thrombosis in cirrhosis.
    Qi XS; Bai M; Fan DM
    World J Gastroenterol; 2014 Aug; 20(32):11463-6. PubMed ID: 25170238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis.
    Xu X; Guo X; De Stefano V; Silva-Junior G; Goyal H; Bai Z; Zhao Q; Qi X
    Hepatol Int; 2019 Jul; 13(4):468-481. PubMed ID: 31175581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients.
    Zampino R; Lebano R; Coppola N; Macera M; Grandone A; Rinaldi L; De Sio I; Tufano A; Stornaiuolo G; Adinolfi LE; Durante-Mangoni E; Battista GG; Niglio A
    Saudi J Gastroenterol; 2018; 24(1):25-29. PubMed ID: 29451181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis.
    Mandorfer M; Bota S; Schwabl P; Bucsics T; Pfisterer N; Kruzik M; Hagmann M; Blacky A; Ferlitsch A; Sieghart W; Trauner M; Peck-Radosavljevic M; Reiberger T
    Gastroenterology; 2014 Jun; 146(7):1680-90.e1. PubMed ID: 24631577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nontumorous Portal Vein Thrombosis in Liver Cirrhosis: Possible Role of β-Blockers.
    Giannitrapani L; Granà W; Licata A; Schiavone C; Montalto G; Soresi M
    Med Princ Pract; 2018; 27(5):466-471. PubMed ID: 30107378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis.
    Pan J; Wang L; Gao F; An Y; Yin Y; Guo X; Nery FG; Yoshida EM; Qi X
    Eur J Intern Med; 2022 Oct; 104():21-32. PubMed ID: 35688747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil extracellular traps formation may be involved in the association of propranolol with the development of portal vein thrombosis.
    Xu X; Xu S; Zhang Y; Wang L; Yan C; Xu Z; Zhao Q; Qi X
    Thromb Res; 2024 Jun; 238():208-221. PubMed ID: 38733693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors associated with portal vein thrombosis in liver cirrhosis: A case-control study.
    Nadinskaia MY; Kodzoeva KB; Ulyanova KA; Volkova AS; Rogacheva SI; Dekhanov AS; Strelkova DA; Ivashkin VT
    Ter Arkh; 2019 Mar; 91(2):73-81. PubMed ID: 31094175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portal vein thrombosis prevalence and associated mortality in cirrhosis in a nationally representative inpatient cohort.
    Cool J; Rosenblatt R; Kumar S; Lucero C; Fortune B; Crawford C; Jesudian A
    J Gastroenterol Hepatol; 2019 Jun; 34(6):1088-1092. PubMed ID: 30307066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonselective beta-blockers and the risk of portal vein thrombosis in patients with cirrhosis: results of a prospective longitudinal study.
    Nery F; Correia S; Macedo C; Gandara J; Lopes V; Valadares D; Ferreira S; Oliveira J; Gomes MT; Lucas R; Rautou PE; Miranda HP; Valla D
    Aliment Pharmacol Ther; 2019 Mar; 49(5):582-588. PubMed ID: 30671978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of factors related to recanalization of portal vein thrombosis in liver cirrhosis: a retrospective cohort study.
    Shi Y; Feng W; Cai J; Wang Z; Pu Y; Mao W; Zhan K; Chen D
    BMC Gastroenterol; 2024 Jul; 24(1):224. PubMed ID: 39003447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis.
    Luca A; Caruso S; Milazzo M; Marrone G; Mamone G; Crinò F; Maruzzelli L; Miraglia R; Floridia G; Vizzini G
    Radiology; 2012 Oct; 265(1):124-32. PubMed ID: 22891357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blockers in patients with advanced liver disease: Has the dust settled?
    Moctezuma-Velazquez C; Kalainy S; Abraldes JG
    Liver Transpl; 2017 Aug; 23(8):1058-1069. PubMed ID: 28590564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single hospital study on portal vein thrombosis in cirrhotic patients - clinical characteristics & risk factors.
    Chen H; Trilok G; Wang F; Qi X; Xiao J; Yang C
    Indian J Med Res; 2014 Feb; 139(2):260-6. PubMed ID: 24718401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation: Analysis of Risk Factors and Outcomes for Portal Vein Thrombosis in Waitlisted Patients.
    Ghabril M; Agarwal S; Lacerda M; Chalasani N; Kwo P; Tector AJ
    Transplantation; 2016 Jan; 100(1):126-33. PubMed ID: 26050013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.
    Cai M; Zhu K; Huang W; Meng X; He K; Zhou B; Guo Y; Chen J; Shan H
    J Vasc Interv Radiol; 2013 Dec; 24(12):1808-16. PubMed ID: 24099787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlational study on portal vein thrombosis of liver cirrhosis].
    Xu DQ; Yang JH
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jul; 28(7):573-579. PubMed ID: 32791792
    [No Abstract]   [Full Text] [Related]  

  • 19. Natural course of nonmalignant partial portal vein thrombosis in cirrhotic patients.
    Girleanu I; Stanciu C; Cojocariu C; Boiculese L; Singeap AM; Trifan A
    Saudi J Gastroenterol; 2014; 20(5):288-92. PubMed ID: 25253363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of non-selective beta blockers in cirrhosis: the evidence we need before closing (or not) the window.
    La Mura V; Tosetti G; Primignani M; Salerno F
    World J Gastroenterol; 2015 Feb; 21(8):2265-8. PubMed ID: 25741132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.